Suppr超能文献

维甲酸对培养心肌细胞中甲状腺激素受体亚型mRNA水平的下调作用。

Downregulation of thyroid hormone receptor subtype mRNA levels by retinoic acid in cultured cardiomyocytes.

作者信息

Drvota V

机构信息

Karolinska Institute at Department of Cardiology, Huddinge University Hospital, Sweden.

出版信息

Biochem Biophys Res Commun. 1998 Jan 26;242(3):593-6. doi: 10.1006/bbrc.1997.8013.

Abstract

The thyroid hormone receptors (TR) and the retinoic acid receptors share a high degree of homology and their signaling pathways interplay. Thyroid hormone (T3) is known to be associated with various pathological heart conditions. Retinoids are known to ameliorate symptoms in hyperthyroid patients. The aim of this study was to investigate if retinoic acid (RA) can have any effects on TR in cardiac cells and thus play a role in heart disease. Confluent AT-1 cardiomyocytes were treated with RA, T3 depleted medium and DITPA (a cardiotonic T3 analogue) for 48 hours. Solution hybridization for the determination of mRNA for TR alpha 1, alpha 1, beta 1 and beta 2 was performed. RA, T3 and DITPA significantly downregulated the alpha 1, beta 1 and beta 2. The T3 depleted medium did not affect the TR subtypes. The specificity of the solution hybridization method was tested by an RNase protection assay. In conclusion, RA downregulates TR in a similar way as T3 in cardiac cells, indicating a role for RA in thyroid associated heart disease.

摘要

甲状腺激素受体(TR)与视黄酸受体具有高度同源性,且它们的信号通路相互作用。已知甲状腺激素(T3)与多种病理性心脏疾病相关。已知类视黄醇可改善甲状腺功能亢进患者的症状。本研究的目的是调查视黄酸(RA)是否会对心脏细胞中的TR产生任何影响,从而在心脏病中发挥作用。将汇合的AT - 1心肌细胞用RA、T3缺失培养基和DITPA(一种强心T3类似物)处理48小时。进行溶液杂交以测定TRα1、α1、β1和β2的mRNA。RA、T3和DITPA显著下调α1、β1和β2。T3缺失培养基不影响TR亚型。通过核糖核酸酶保护试验测试了溶液杂交方法的特异性。总之,RA在心脏细胞中以与T3类似的方式下调TR,表明RA在甲状腺相关心脏病中发挥作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验